These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38606424)

  • 1. Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research.
    Tsai YN; Wu JL; Hsu YC
    Clin Mol Hepatol; 2024 Apr; 30(2):276-278. PubMed ID: 38606424
    [No Abstract]   [Full Text] [Related]  

  • 2. Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma.
    Wu JW; Kao JH; Tseng TC
    Clin Mol Hepatol; 2021 Oct; 27(4):524-534. PubMed ID: 33618507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critique and systematic review of the clinical utility of hepatitis B core-related antigen.
    Adraneda C; Tan YC; Yeo EJ; Kew GS; Khakpoor A; Lim SG
    J Hepatol; 2023 Apr; 78(4):731-741. PubMed ID: 36586590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy.
    Carey I; Gersch J; Wang B; Moigboi C; Kuhns M; Cloherty G; Dusheiko G; Agarwal K
    Hepatology; 2020 Jul; 72(1):42-57. PubMed ID: 31701544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients.
    Li J; Wu Z; Wang GQ; Zhao H
    Chin Med J (Engl); 2021 Mar; 134(10):1160-1167. PubMed ID: 33734135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
    Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B core-related antigen: Are we near a treatment endpoint?
    Gupta T
    World J Gastroenterol; 2022 Jul; 28(27):3532-3534. PubMed ID: 36158266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and Value of Hepatitis B Core-Related Antigen in Patients with Chronic Hepatitis B Virus Infection during Antiviral Treatment.
    Sandmann L; Bremer B; Ohlendorf V; Jaroszewicz J; Wedemeyer H; Cornberg M; Maasoumy B
    Viruses; 2024 Feb; 16(2):. PubMed ID: 38400031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correspondence on Editorial regarding "HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB".
    Mak LY; Seto WK; Yuen MF
    Clin Mol Hepatol; 2023 Jan; 29(1):191-193. PubMed ID: 36417889
    [No Abstract]   [Full Text] [Related]  

  • 11. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy.
    Mak LY; Cloherty G; Wong DK; Gersch J; Seto WK; Fung J; Yuen MF
    Hepatology; 2021 Jun; 73(6):2167-2179. PubMed ID: 33159329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline and on-treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals.
    Hwang SY; Yoo SH; Chang HY; Kim S; Lee JI; Lee KS; Cho YY; Joon KH; Lee HW
    J Viral Hepat; 2023 Jan; 30(1):39-45. PubMed ID: 36321949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation.
    Tsai YN; Wu JL; Tseng CH; Chen TH; Wu YL; Chen CC; Fang YJ; Yang TH; Nguyen MH; Lin JT; Hsu YC
    Clin Mol Hepatol; 2024 Jan; 30(1):98-108. PubMed ID: 38092551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of detecting HBV pgRNA and HBcrAg in HBV patients treated with NAs.
    Lin J; Jiang S; Chen X; Zhu M; Zhang H
    Medicine (Baltimore); 2024 Apr; 103(14):e37752. PubMed ID: 38579047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B Core-Related Antigen: From Virology to Clinical Application.
    Lee HW; Ahn SH; Chan HL
    Semin Liver Dis; 2021 May; 41(2):182-190. PubMed ID: 33957693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.
    Mak LY; Wong DK; Cheung KS; Seto WK; Lai CL; Yuen MF
    Aliment Pharmacol Ther; 2018 Jan; 47(1):43-54. PubMed ID: 29035003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literature.
    Afifi AM; Elgenidy A; Hashim M; Awad AK; Jalal PK
    Rev Med Virol; 2022 Nov; 32(6):e2353. PubMed ID: 35441759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Hepatitis B Core-Related Antigen Versus Hepatitis B Surface Antigen and Hepatitis B Virus DNA in Predicting HBeAg-positive and HBeAg-negative Chronic Hepatitis.
    Zhang ZQ; Wang YB; Lu W; Liu DP; Shi BS; Zhang XN; Huang D; Li XF; Zhou XL; Ding RR
    Ann Lab Med; 2019 Jan; 39(1):67-75. PubMed ID: 30215232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance.
    King WC; Sterling RK; Hinerman AS; Lok ASF; Cloherty GA; Ghany MG;
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1957-1959. PubMed ID: 35850413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.